Pharmacologically active compounds with preferential cytotoxic activity for senescent cells, known as senolytics, can ameliorate or even revert pathological manifestations of senescence in numerous preclinical mouse disease models, including cancer models. However, translation of senolytic therapies to human disease is hampered by their suboptimal specificity for senescent cells and important toxicities that narrow their therapeutic windows. We have previously shown that the high levels of senescence-associated lysosomal β-galactosidase (SA-β-gal) found within senescent cells can be exploited to specifically release tracers and cytotoxic cargoes from galactose-encapsulated nanoparticles within these cells. Here, we show that galacto-conjugation of the BCL-2 family inhibitor Navitoclax results in a potent senolytic prodrug (Nav-Gal), that can be preferentially activated by SA-β-gal activity in a wide range of cell types. Nav-Gal selectively induces senescent cell apoptosis and has a higher senolytic index than Navitoclax (through reduced activation in nonsenescent cells).Nav-Gal enhances the cytotoxicity of standard senescence-inducing chemotherapy (cisplatin) in human A549 lung cancer cells. Concomitant treatment with cisplatin and Nav-Gal in vivo results in the eradication of senescent lung cancer cells and significantly reduces tumour growth. Importantly, galacto-conjugation reduces Navitoclaxinduced platelet apoptosis in human and murine blood samples treated ex vivo, and thrombocytopenia at therapeutically effective concentrations in murine lung cancer models. Taken together, we provide a potentially versatile strategy for generating effective senolytic prodrugs with reduced toxicities.

Highlights► 11β-HSD1 converts inert glucocorticoids into active forms, amplifying glucocorticoid action. ► 11β-HSD1 is markedly induced by pro-inflammatory cytokines. ► 11β-HSD1 deficiency/inhibition worsens acute inflammation. ► 11β-HSD1 inhibition reduces inflammation in obesity or atherosclerosis. ► An increased angiogenic response may underlie some of the benefits.

The photo‐oxidative degradation of polyethylene/montmorillonite (PE/MMT) nanocomposite and microcomposite has been investigated. It has been found that the rate of photo‐oxidative degradation of PE/MMT nanocomposite and PE/Mn+MMT (where Mn+ stands for multivalent transition metal cation) microcomposites is much faster than that of pure PE. For the PE/MMT nanocomposite, the acceleration of photo‐oxidative degradation is due to the influence of MMT and ammonium ion, in which the influence of ammonium is primary. The decomposition of ammonium ion may create acidic sites on layered silicates; meanwhile, the complex crystallographic structure and habit of clay minerals could also result in some active sites. The reversible photo‐redox reaction of transition metal cations has a catalytic effect in the degradation of the polymer matrix. All these catalytic active sites can accept single electrons from donor molecules of polymer matrix and induce the formation of free radical upon UV irradiation. The generation of free radical leads to the oxidization and break of molecular chain. Thus, the materials suffer degradation and their mechanical strength decreases. © 2004 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 42: 3006–3012, 2004